Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherRevenue - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Perspective Therapeutics (CATX) Cost of Revenue (2016 - 2023)

Perspective Therapeutics' Cost of Revenue history spans 14 years, with the latest figure at -$4.9 million for Q4 2023.

  • On a quarterly basis, Cost of Revenue changed N/A to -$4.9 million in Q4 2023 year-over-year; TTM through Dec 2023 was -$1.7 million, a N/A change, with the full-year FY2022 number at $2.8 million, down 43.15% from a year prior.
  • Cost of Revenue hit -$4.9 million in Q4 2023 for Perspective Therapeutics, down from $1.4 million in the prior quarter.
  • Over the last five years, Cost of Revenue for CATX hit a ceiling of $3.2 million in Q2 2021 and a floor of -$4.9 million in Q4 2023.
  • Historically, Cost of Revenue has averaged $547473.7 across 5 years, with a median of $702000.0 in 2021.
  • Biggest five-year swings in Cost of Revenue: crashed 179.85% in 2019 and later skyrocketed 947.04% in 2021.
  • Tracing CATX's Cost of Revenue over 5 years: stood at $666000.0 in 2019, then dropped by 7.06% to $619000.0 in 2020, then increased by 13.41% to $702000.0 in 2021, then rose by 13.96% to $800000.0 in 2022, then plummeted by 707.88% to -$4.9 million in 2023.
  • Business Quant data shows Cost of Revenue for CATX at -$4.9 million in Q4 2023, $1.4 million in Q3 2023, and $911000.0 in Q2 2023.